Minority diseases are a major challenge for the health system, since they often have a genetic origin, can affect many organs, be serious, represent a life threatening or being chronically debilitating. They are difficult to diagnose and have little therapeutic options; because of its characteristics require an approach multidisciplinary.
Minority diseases; Orphan drugs; Economic cost
Tractament de malalties minoritàries amb medicaments orfes d'autorització individual. Barcelona: Servei Català de la Salut; 2019.
Use this identifier for quote and/or link this documenthttps://hdl.handle.net/11351/4025
This item appears in following collections
The following license files are associated with this item: